Literature DB >> 10621535

Management of neurotrophic keratopathy.

A Lambiase1, P Rama, L Aloe, S Bonini.   

Abstract

Neurotrophic keratopathy is a degenerative corneal disease caused by an impairment of corneal sensitivity. Lack of the sensory nerve's trophic effect is responsible for the impairment in corneal healing and for the changes on the ocular surface that lead to corneal epithelial deficit, ulcer, and perforation. The etiology and recent advances in understanding of the pathogenetic mechanisms of neurotrophic keratopathy are reviewed here. An accurate history and a clinical examination that covers the function of cranial nerves often identify the cause of the disease. Clinical features and guidelines for the differential diagnosis and treatment are presented. Specific medical and surgical treatments, selected on the basis of clinical staging of the disease, can often halt disease progression. Future developments in medical treatment, including the use of neuropeptide and growth factors, are discussed. The identification of corneal anesthesia associated with an epithelial defect allows appropriate treatment and prevention of progression to stromal lysis and perforation.

Entities:  

Mesh:

Year:  1999        PMID: 10621535     DOI: 10.1097/00055735-199908000-00009

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  27 in total

Review 1.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

2.  [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].

Authors:  A Schilimow; B Wiechens
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

Review 3.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

4.  Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.

Authors:  Ronald Mauricio Sanchez-Avila; Jesus Merayo-Lloves; Ana Cristina Riestra; Luis Fernandez-Vega Cueto; Eduardo Anitua; Leire Begoña; Francisco Muruzabal; Gorka Orive
Journal:  Int Ophthalmol       Date:  2017-06-15       Impact factor: 2.031

5.  Eyelid reanimation, neurotisation, and transplantation of the cornea in a patient with facial palsy.

Authors:  Fabiana Allevi; Paolo Fogagnolo; Luca Rossetti; Federico Biglioli
Journal:  BMJ Case Rep       Date:  2014-08-19

Review 6.  Progress in corneal wound healing.

Authors:  Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  Prog Retin Eye Res       Date:  2015-07-18       Impact factor: 21.198

7.  PEDF plus DHA modulate inflammation and stimulate nerve regeneration after HSV-1 infection.

Authors:  Jiucheng He; Donna Neumann; Azucena Kakazu; Thang Luong Pham; Farhana Musarrat; M Soledad Cortina; Haydee E P Bazan
Journal:  Exp Eye Res       Date:  2017-06-20       Impact factor: 3.467

8.  Corneal nerve regeneration in neurotrophic keratopathy following autologous plasma therapy.

Authors:  Kavita Rao; Christopher Leveque; Stephen C Pflugfelder
Journal:  Br J Ophthalmol       Date:  2009-12-03       Impact factor: 4.638

9.  Cocaine snorting may induce ocular surface damage through corneal sensitivity impairment.

Authors:  Flavio Mantelli; Alessandro Lambiase; Marta Sacchetti; Valerio Orlandi; Alba Rosa; Pietro Casella; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-03       Impact factor: 3.117

Review 10.  Bilateral Alterations in Corneal Nerves, Dendritic Cells, and Tear Cytokine Levels in Ocular Surface Disease.

Authors:  Takefumi Yamaguchi; Pedram Hamrah; Jun Shimazaki
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.